(Thom Leach/Science Photo Library/Getty Images) A powerful advance in cancer-fighting medicine has achieved an extraordinary ...

Typewriter harnesses a non-viral approach as viral vectors increasingly come under the spotlight for their associated safety ...

A 24-year-old Long Island man is fighting back from a severe brain injury after being struck while walking to work. His ...

The overall cancer death rate in the U.S. fell 35% between 1991 and 2024, a decline that has prevented more than 4.8 million cancer deaths, according to the American Association for Cancer Research’s ...

Researchers from the University of Miami Miller School of Medicine and collaborating institutions have published a ...

Now in its 16th edition, the report notes that the overall cancer death rate in the US fell 35% between 1991 and 2024—translating to 4.8 million fewer deaths—a decline the report credits to decades of ...

Editas Medicine (EDIT) stays a Hold as EDIT-401 nears trials; preclinical 90%+ LDL-C reduction for HeFH, but dilution and competition loom—read more macroanalysis here.

Zanvastro, an antisense oligonucleotide therapy, represents the first independent neurology launch for Ionis Pharmaceuticals, ...

HIV doesn’t discriminate, but societal barriers have left Black Americans disproportionately affected. HIV prevention options ...

A well-connected family’s fight to access a potential treatment for their son highlights the barriers most rare disease patients struggle to overcome.

What can families do when teen anxiety begins to interfere with school, friendships, and daily routines in the North Indianapolis suburbs? The answer is provided in a HelloNation article featuring ...

FDA approval of Scholar Rock’s ISEMBYLD (apitegromab) for SMA drives a Strong Buy case, with $2B+ market upside and EU/JP ...